BRPI0920965A2 - método para produzir derivados funcionalizados de ácido hialurônico e a formação de hidrogéis a partir dos mesmos - Google Patents

método para produzir derivados funcionalizados de ácido hialurônico e a formação de hidrogéis a partir dos mesmos

Info

Publication number
BRPI0920965A2
BRPI0920965A2 BRPI0920965A BRPI0920965A BRPI0920965A2 BR PI0920965 A2 BRPI0920965 A2 BR PI0920965A2 BR PI0920965 A BRPI0920965 A BR PI0920965A BR PI0920965 A BRPI0920965 A BR PI0920965A BR PI0920965 A2 BRPI0920965 A2 BR PI0920965A2
Authority
BR
Brazil
Prior art keywords
hydrogels
formation
hyaluronic acid
functionalized derivatives
producing functionalized
Prior art date
Application number
BRPI0920965A
Other languages
English (en)
Inventor
Giammona Gaetano
Palumbo Fabio
Pittarresi Giovanna
Original Assignee
Università Degli Studi Di Palermo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Università Degli Studi Di Palermo filed Critical Università Degli Studi Di Palermo
Publication of BRPI0920965A2 publication Critical patent/BRPI0920965A2/pt
Publication of BRPI0920965B1 publication Critical patent/BRPI0920965B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K9/00—Arc welding or cutting
    • B23K9/10—Other electric circuits therefor; Protective circuits; Remote controls

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Plasma & Fusion (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Arc Welding Control (AREA)
BRPI0920965-4A 2008-11-28 2009-11-30 Método para produzir derivados funcionalizados de ácido hialurônico e a formação de hidrogéis a partir dos mesmos BRPI0920965B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000636A ITRM20080636A1 (it) 2008-11-28 2008-11-28 Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
ITRM2008A000636 2008-11-28
PCT/EP2009/066060 WO2010061005A1 (en) 2008-11-28 2009-11-30 Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof

Publications (2)

Publication Number Publication Date
BRPI0920965A2 true BRPI0920965A2 (pt) 2016-09-06
BRPI0920965B1 BRPI0920965B1 (pt) 2019-07-09

Family

ID=41210473

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920965-4A BRPI0920965B1 (pt) 2008-11-28 2009-11-30 Método para produzir derivados funcionalizados de ácido hialurônico e a formação de hidrogéis a partir dos mesmos

Country Status (15)

Country Link
US (2) US8858999B2 (pt)
EP (1) EP2370474B1 (pt)
JP (1) JP5607061B2 (pt)
CN (1) CN102227448B (pt)
BR (1) BRPI0920965B1 (pt)
CA (1) CA2744892C (pt)
DK (1) DK2370474T3 (pt)
ES (1) ES2397987T3 (pt)
HK (1) HK1162546A1 (pt)
IT (1) ITRM20080636A1 (pt)
MX (1) MX2011005528A (pt)
PL (1) PL2370474T3 (pt)
RU (1) RU2523182C2 (pt)
SI (1) SI2370474T1 (pt)
WO (1) WO2010061005A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112812200A (zh) * 2019-11-18 2021-05-18 孛朗孚有限公司 巯基改性高分子化合物及其制备方法和用途

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
ITRM20080636A1 (it) 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
NZ602405A (en) 2010-03-12 2014-12-24 Allergan Ind Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
IT1401498B1 (it) 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
CZ304072B6 (cs) * 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
EP2714002B1 (en) 2011-06-03 2019-04-03 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
JP5714456B2 (ja) * 2011-09-07 2015-05-07 株式会社シード 重合性ヒアルロン酸誘導体、ならびにその重合体を含むヒアルロン酸ヒドロゲルおよびコンタクトレンズ
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
KR101240518B1 (ko) * 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
US20150111812A1 (en) 2012-05-31 2015-04-23 Cornell University Polysaccharide-based hydrogels and hybrid hydrogels and precursors thereof, methods of making same, and uses thereof
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ2012843A3 (cs) 2012-11-27 2014-02-05 Contipro Biotech S.R.O. Nekonečná vlákna na bázi hyaluronanu, selektivně oxidovaného v poloze 6 N-acetyl-D-glukosaminové části, jejich příprava, použití, nitě, střiže, příze, textilie a způsob jejich úpravy
CZ2012842A3 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
US20140275340A1 (en) * 2013-03-15 2014-09-18 Lake Region Manufacturing, Inc. d/b/a Lake Region Medical Modified hyaluronate hydrophilic compositions, coatings and methods
US9623157B2 (en) 2013-03-15 2017-04-18 Lake Region Manufacturing, Inc. Modified hyaluronate hydrophilic compositions, coatings and methods
CN105517580A (zh) * 2013-03-15 2016-04-20 马修·R·德勒埃 可成像栓塞微球
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CN103910886B (zh) * 2014-03-24 2016-04-06 海南大学 半胱氨酸功能化的透明质酸结合物及其合成方法以及在可注射原位形成的水凝胶中的应用
TR201809421T4 (tr) * 2014-05-07 2018-07-23 Nemysis Ltd Çölyak hastaliğinda oral enzi̇m tedavi̇si̇ i̇çi̇n metakri̇li̇k hi̇yalüroni̇k asi̇t türevleri̇ni̇n hi̇drojelleri̇.
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
EP3288658B1 (en) * 2015-04-29 2020-08-26 Waters Technologies Corporation High purity chromatographic materials comprising ion paired-bonded phases for supercritical fluid chromatography
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
EP3337523B1 (en) 2015-08-19 2022-04-27 University of Iowa Research Foundation Preventative therapy for post-traumatic osteoarthritis
EP3156044A1 (en) * 2015-10-16 2017-04-19 Merz Pharma GmbH & Co. KGaA In situ cross-linkable polysaccharide compositions and uses thereof
SI3397651T1 (sl) 2015-12-29 2020-11-30 Galderma S.A. Oglikovodično zamreževalo
CN105770983B (zh) * 2016-03-14 2019-02-19 武汉纺织大学 一种透明质酸生物粘合剂的制备方法
JP6675247B2 (ja) * 2016-03-28 2020-04-01 株式会社シード フィブロイン−ヒアルロン酸ハイドロゲル複合体
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN106279729A (zh) * 2016-08-26 2017-01-04 北京大清生物技术有限公司 一种透明质酸交联凝胶及其制备方法与应用
FR3060239A1 (fr) * 2016-12-14 2018-06-15 Ge Energy Products France Snc Procede de determination d'un profil de reponse en statisme d'une machine electrique reliee a un reseau electrique
JP2018153296A (ja) * 2017-03-16 2018-10-04 Jsr株式会社 不飽和化合物を含有する組成物
WO2018175788A1 (en) 2017-03-22 2018-09-27 Genentech, Inc. Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
US10263552B2 (en) * 2017-08-08 2019-04-16 Rolls-Royce North American Technologies Inc. Anticipatory control using output shaft speed
CN108187130B (zh) * 2017-09-15 2020-08-18 海宁侏罗纪生物科技有限公司 一种用于生物损伤修复或止血的试剂及其应用
IT201700122135A1 (it) * 2017-10-26 2019-04-26 Jointherapeutics S R L Acido ialuronico funzionalizzato o suo derivato nel trattamento di stati infiammatori
WO2019178825A1 (zh) * 2018-03-23 2019-09-26 高雄医学大学 玻尿酸水胶微粒的制备方法及其修复关节软骨缺损的用途
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
CN110384822B (zh) * 2019-08-19 2021-11-16 江苏人冠医疗科技有限公司 眼用粘合封闭胶及其制备方法
CN110433320A (zh) * 2019-09-12 2019-11-12 深圳刚华健医疗有限公司 一种医用敷料的制备方法
EP4069753A1 (en) 2019-12-02 2022-10-12 Galderma Holding SA High molecular weight esthetic compositions
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN114269813B (zh) * 2020-06-01 2024-01-02 株式会社Lg化学 制备聚合物微粒的方法，聚合物微粒，使用其的医用组合物、美容组合物、医用制品和美容制品
IT202000028445A1 (it) 2020-11-25 2022-05-25 Univ Degli Studi Di Palermo Nanosistema per la diagnosi ed il trattamento fototermico di tumori
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN115636884B (zh) * 2022-12-23 2023-03-28 北京格林意锐医药科技有限责任公司 一种透明质酸钠衍生物制备方法及交联透明质酸钠和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06279501A (ja) * 1993-03-29 1994-10-04 Asahi Chem Ind Co Ltd カーボネート化セルロース誘導体及びその製造方法
JPH06279502A (ja) * 1993-03-29 1994-10-04 Asahi Chem Ind Co Ltd カーボネート化セルロース誘導体の製法
IT1268955B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Esteri attivi di polisaccaridi carbossilici
US6031017A (en) * 1995-11-15 2000-02-29 Seikagaku Corporation Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
RU2191782C2 (ru) * 2000-09-21 2002-10-27 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения модифицированной гиалуроновой кислоты
JP2004292465A (ja) * 2000-11-30 2004-10-21 Denki Kagaku Kogyo Kk ヒドロキサム酸誘導体とヒアルロン酸の結合体
ITTS20010013A1 (it) * 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
WO2003002125A2 (en) * 2001-06-29 2003-01-09 Astion A/S Combination of aminosugars and cysteine or cysteine derivatives
WO2005023906A1 (ja) * 2003-09-08 2005-03-17 Chugai Seiyaku Kabushiki Kaisha ヒアルロン酸修飾物、及びそれを用いた薬物担体
GB2408741B (en) * 2003-12-04 2008-06-18 Ind Tech Res Inst Hyaluronic acid derivative with urethane linkage
TW200536861A (en) * 2004-04-02 2005-11-16 Denki Kagaku Kogyo Kk Hyaluronic acid/methotrexate compound
EP1790665B1 (en) * 2004-09-07 2014-11-05 Chugai Seiyaku Kabushiki Kaisha Process for producing water-soluble modified hyaluronic acid
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100849185B1 (ko) * 2006-01-19 2008-07-30 서울산업대학교 산학협력단 키토산 또는 히알루론산-폴리에틸렌옥사이드 및키토산-히알루론산-폴리에틸렌옥사이드를 기저로 하는하이드로젤과　 이의 제조방법
ITRM20080636A1 (it) 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112812200A (zh) * 2019-11-18 2021-05-18 孛朗孚有限公司 巯基改性高分子化合物及其制备方法和用途

Also Published As

Publication number Publication date
ITRM20080636A1 (it) 2010-05-29
CN102227448A (zh) 2011-10-26
WO2010061005A1 (en) 2010-06-03
JP2012510535A (ja) 2012-05-10
BRPI0920965B1 (pt) 2019-07-09
ES2397987T3 (es) 2013-03-12
CN102227448B (zh) 2014-04-02
MX2011005528A (es) 2011-08-17
US20110236486A1 (en) 2011-09-29
JP5607061B2 (ja) 2014-10-15
RU2523182C2 (ru) 2014-07-20
SI2370474T1 (sl) 2013-02-28
HK1162546A1 (en) 2012-08-31
DK2370474T3 (da) 2013-01-14
CA2744892A1 (en) 2010-06-03
RU2011126353A (ru) 2013-01-10
CA2744892C (en) 2016-10-25
EP2370474B1 (en) 2012-10-24
US8858999B2 (en) 2014-10-14
PL2370474T3 (pl) 2013-03-29
US20150183891A1 (en) 2015-07-02
EP2370474A1 (en) 2011-10-05
US9410000B2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
BRPI0920965A2 (pt) método para produzir derivados funcionalizados de ácido hialurônico e a formação de hidrogéis a partir dos mesmos
BRPI0913622A2 (pt) Processo para a produção fermentativa de eritropoietina
BRPI0916568A2 (pt) método de produção de particulas de polissacarídeo reticuladas
BRPI0812232A2 (pt) Método para produção de polissacarídeo solúvel em água
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
PT2225289T (pt) Método para fabrico de dispersões aquosas de polímeros
BRPI0905928A2 (pt) "método de produção de ácido lático"
BRPI0909655A2 (pt) Processo para a preparação regioseletiva de derivados de ácido 1-alquil-3-haloalquil-pirazol-4carboxílico
BRPI0916239A2 (pt) método para produção de ácido propiônico de recursos biológicos a partir de glicerol
BRPI0922710A2 (pt) método para a produção de plaquetas
BRPI1010572A2 (pt) processo para produção de uma metálica revestida de aparência melhorada.
BRPI0811828A2 (pt) "método de produção de ácido lático"
IL208834A0 (en) Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
BRPI0923109A8 (pt) método para a produção de derivados de diamina
BRPI0919835A2 (pt) método para a produção de polímeros
EP2239280A4 (en) METHOD FOR PRODUCING POLYMERMIC PARTICLES
BR112012001274A2 (pt) processo para produção de ácidos decancarboxílicos
BRPI0907872A2 (pt) Processo para produção de ácido dicarboxílico
EP1997844A4 (en) PROCESS FOR PREPARING CONJUGATED POLYMER
EP2311971A4 (en) METHOD FOR PRODUCING HYALURONIC ACID
BRPI0915080A2 (pt) dispositivos, processos e métodos para a produção de ésteres de alquílicos inferiores
EP2239278A4 (en) PROCESS FOR THE PRODUCTION OF POLYMER MICROPARTICLES
PL2239279T3 (pl) Sposób wytwarzania mikrocząstek polimerowych
IL205745A0 (en) Method for the production of 2-fluoroacyl-3-amino-acrylic acid derivatives
PL2239277T3 (pl) Sposób wytwarzania mikrocząstek polimerowych

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2009, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.